-
(a)
-
(1) An approved drug court program shall collect and provide monthly data on drug court applicants and all participants as required by the Specialty Court Program Advisory Committee in accordance with the rules promulgated under § 10-3-2901.
-
(2) The data shall include:
-
(A) The total number of applicants;
-
(B) The total number of participants;
-
(C) The total number of successful applicants;
-
(D) The total number of successful participants;
-
(E) The total number of unsuccessful participants and the reason why each unsuccessful participant did not complete the drug court program;
-
(F) Information about what happened to each unsuccessful participant;
-
(G) The total number of participants who were arrested for a new criminal offense while in the drug court program;
-
(H) The total number of participants who were convicted of a new criminal offense while in the drug court program;
-
(I) The total number of participants who committed a violation of one (1) or more conditions of the drug court program and the resulting sanction;
-
(J) The results of the initial risk-needs assessment or other appropriate clinical assessment conducted on each participant;
-
(K) The total amount of time each program participant was in the drug court program; and
-
(L) Any other data or information as required by the Specialty Court Program Advisory Committee in accordance with the rules promulgated under § 10-3-2901.
-
-
-
(b) The data collected for evaluation purposes under subsection (a) of this section shall:
-
(1) Include a minimum standard data set developed and specified by the Specialty Court Program Advisory Committee; and
-
(2) Be maintained in the court files or be otherwise accessible by the courts and the Specialty Court Program Advisory Committee.
-
-
(c)
-
(1) As directed by the Specialty Court Program Advisory Committee, after an individual is discharged either upon completion or termination of a drug court program, the drug court program shall conduct, as much as practical, follow-up contacts with and reviews of former drug court participants for key outcome indicators of drug use, recidivism, and employment.
-
(2)
-
(A) The follow-up contacts with and reviews of former drug court participants shall be conducted as frequently and for a period of time as determined by the Specialty Court Program Advisory Committee based upon the nature of the drug court program and the nature of the participants.
-
(B) The follow-up contacts with and reviews of former drug court participants are not extensions of the drug court’s jurisdiction over the drug court participants.
-
-
-
(d) For purposes of standardized measurement of success of drug court programs across the state, the Specialty Court Program Advisory Committee shall adopt an operational definition of terms such as “recidivism”, “retention”, “relapses”, “restarts”, “sanctions imposed”, and “incentives given” to be used in any evaluation and report of drug court programs.
-
(e) Each drug court program shall provide to the Specialty Court Program Advisory Committee all information requested by the Specialty Court Program Advisory Committee.
-
(f) The Division of Drug Court Programs, the Division of Community Correction, the Division of Aging, Adult, and Behavioral Health Services of the Department of Human Services, and the Arkansas Crime Information Center shall work together to share and make available data to provide a comprehensive data management system for the state’s drug court programs.
-
(g) The Administrative Office of the Courts shall collect monthly data reports submitted by approved drug courts and provide the monthly data reports to the Specialty Court Program Advisory Committee.
-
(h) The Specialty Court Program Advisory Committee shall:
-
(1) Submit a report by July 1 of each year summarizing the data collected and outcomes achieved by all approved drug courts; and
-
(2) Contract with a third-party evaluator every three (3) years to conduct an evaluation on the effectiveness of the drug court program in complying with the key components of § 16-98-302(b).
-
